Insider Transactions Reported by 22 Insiders of Century Therapeutics, Inc.

Symbol
IPSC on Nasdaq
Location
Philadelphia, PA

Insiders trading volume in the past year

Century Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
BAYER AKTIENGESELLSCHAFT 10%+ Owner $18,886,999 22 Jun 2021
Versant Venture Capital VI, L.P. 10%+ Owner $18,127,503 09 Aug 2022
FUJIFILM Cellular Dynamics, Inc. 10%+ Owner $10,363,258 22 Jun 2021
Brent Pfeiffenberger President and CEO, Director $7,344,392 +$16,271 +0.22% 06 Mar 2026
Hyam Levitsky President of R&D $2,880,972 07 Mar 2024
Gregory Russotti Title: Chief Technology and Manufacturing Officer $1,513,582 -$2,091 -0.14% 09 Mar 2026
Douglas Carr SVP Finance & Operations $1,304,274 -$5,025 -0.38% 09 Mar 2026
Chad Cowan Chief Scientific Officer $1,126,384 +$46,516 +4.3% 02 Feb 2026
Luis Borges Chief Scientific Officer $382,237 03 Apr 2023
Michael Craig Diem Chief Financial Officer $377,764 01 Nov 2023
Adrienne Farid Chief Operations Officer $155,587 -$907 -0.58% 09 Jun 2025
Morgan Conn Chief Finanical Officer $48,984 11 Mar 2025
Daphne Quimi Director $7,657 12 Jun 2025
CYNTHIA M. BUTITTA Director 12 Jun 2025
Alessandro Riva Director 12 Jun 2025
Rizzuto Carlo Director 12 Jun 2025
Osvaldo Flores Chief Executive Officer 02 Feb 2023
JOSEPH JIMENEZ Director 12 Jun 2025
Han Myung Lee Director 09 Dec 2025
Eli Casdin Director 09 Jun 2022
Kimberly Blackwell Director 12 Jun 2025
Timothy P. Walbert Director 12 Jun 2025

Recent Insider Transactions by Companies or Individuals for Century Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.